DCT and melanoma: Consistent with downregulation of the melanocyte differentiation markers and key enzymes for melanin synthesis, TYRP1 and TYRP2, (Figure 2), pathway expression for the melanin biosynthesis pathway was markedly downregulated in CD133-expressing BAKP melanoma cells (Figure 3D).